|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�߲��� |
|
c-kit���� |
| ��������������� | |
|
��ΰƽ |
|
½�� |
| PubMed | |
|
Article by |
|
Article by |
�߲������о���չ
��ΰƽ, ½��
��ɽ��ѧ��������ҽԺƤ���Բ��� ���� 510630
�߲�����һ���ټ��������Գ�Ⱦɫ�������Ŵ���Ƥ����,���ŷ�������ѧ�����ķ�չ,���Ƕ߲������²����������Ƶ���ʶҲ��һ������.���дӰ߲����ķ������ơ�ͻ�����ͼ������ٴ����͵Ĺ�ϵ�Լ����Ʒ��������߲������о���չ.
�㶫ʡ��Ȼ��ѧ��������(031655)
[2] Robertson SC,Tynan JA,Donoghue DJ.RTK mutations and human syndromeswhen good receptors turn bad.Trends Genet,2000,16:265-271.
[3] Tomita Y,Miyamura Y,Kono M,et al.Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan.Pigment Cell Res,2000,13:130-134.
[4] Spritz RA,Beighton P.Piebaldism with deafness:molecular evidence for an expanded syndrome.Am J Med Genet,1998,75:101-103.
[5] Syrris P,Malik NM,Murday VA,et al.Three novel mutations of the proto-oncogene KIT cause human piebaldism.Am J Med Genet,2000,95:79-81.
[6] Spritz RA,Holmes SA,Ramesar R,et al.Mutations of the KIT(mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.Am J Hum Genet,1992,51:1058-1065.
[7] Syrris P,Heathcote K,Carrozzo R,et al.Human piebaldism:six novel mutations of the proto-oncogene KIT.Hum Mutat,2002,20:234.
[8] Spritz RA,Giebel LB,Holmes SA.Dominant negative and loss of function mutations of the c-kit(mast/stem cell growth factor receptor)proto-oncogene in human piebaldism,Am J Hum Genet,1992,50:261-269.
[9] Nomura K,Hatayama I,Narita T,et al.A novel KIT gene missense mutation in a Japanese family with piebaldism.J Invest Dermatol,1998,111:337-338.
[10] Spritz RA,Droetto S,Fukushima Y.Deletion of the KIT and PDGFRA genes in a patient with piebaldism.Am J Med Genet,1992,44:492-495.
[11] Ramadevi AR,Naik U,Dutta U,et al.De novo pericentric inversion of chromosome 4,inv(4)(p16q12) in a boy with piebaldism and mental retardation.Am J Med Genet,2002,113:190-192.
[12] Ward KA,Moss C,Sanders DS.Human piebaldism:relationship between phenotype and site of kit gene mutation.Br J Dermatol,1995,132:929-935.
[13] Richards KA,Fukai K,Oiso N,et al.A novel KIT mutation results in piebaldism with progressive depigmentation.J Am Acad Dermatol,2001,44:288-292.
[14] Angelo C,Cianchini G,Grosso MG,et al.Association of piebaldism and neurofibromatosis type 1 in a girl.Pediatr Dermatol,2001,18:490-493.
[15] Kiwan RA,Mutasim DF.Grover disease(transient acantholytic dermatosis) and piebaldism.Cutis,2002,69:451-453.
[16] Koklu S,Ertugrul D,Onat AM,et al.Piebaldism associated with congenital dyserythropoietic anemia type ��(HEMPAS).Am J Hematol,2002,69:210-213.
[17] Njoo MD,Nieuweboer-Krobotova L,Westerhof W.Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin splitthickness skin grafting in combination with minigrafting.Br J Dermatol,1998,139:829-833.
[18] Horikawa T,Mishima Y,Nishino K,et al.Horizontal and vertical pigment spread into surrounding piebald epidermis and hair follicles after suction blister epidermal grafting.Pigment Cell Res,1999,12:175-180.
[19] Olsson MJ,Juhlin L.Leucoderma treated by transplantation of a basal cell layer enriched suspension.Br J Dermatol,1998,138:644-648.
[20] Olsson M J,Juhlin L.Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes,ultrathin epidermal sheets and basal cell layer suspension.Br J Dermatol,2002,147:893-904.
[21] Ongenae K,van Geel N,Naeyaert JM.Autologous cellular suspensions and sheets in the treatment of achromic disorders:the need for future controlled studies.Dermatology,2001,202:158-161.
[22] Alexeev V,Igoucheva O,Yoon K.Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides.Gene Ther,2002,9:1667-1675.